Literature DB >> 1190754

Inhibition of protein synthesis in intact HeLa cells.

J S Tscherne, S Pestka.   

Abstract

Polysome analysis has proved to be a sensitive probe for the mode of action of inhibitors of protein synthesis in intact HeLa cells. To classify the active compounds as inhibitors of initiation, elongation, or termination, their effects on the cellular polyribosome pattern were compared under three conditions. These conditions tested (i) their direct effect on the polyribosome profile; (ii) their effect on ribosome run-off produced by hypertonicity; and (iii) their effects on recovery from hypertonicity. Using this technique, diacetoxyscirpenol, 2-(4-methyl-2,6-dinitroanilino)-N-methylpropionamide, and three alkaloids, harringtonine, isoharringtonine, and homoharringtonine, were found to be inhibitors of initiation. Polysome analysis indicated that in HeLa cells 7.8 x 10(-7) M pactamycin, which inhibited protein synthesis 94%, interfered with elongation as well as initiation under these conditions. Emetine, anisomycin, cycloheximide, and trichodermin each gave polysome patterns consistent with inhibition of elongation. Fusidic acid and aurintricarboxylic acid inhibited incorporation of [(14)C]leucine into intact HeLa cells, but polysome analysis did not localize any specific inhibitory effects to the initiation, elongation, or termination steps of protein synthesis. The use of specific inhibitors of initiation of protein synthesis has indicated that most, if not all, mammalian messenger ribonucleic acids contain a single initiation site.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1190754      PMCID: PMC429376          DOI: 10.1128/AAC.8.4.479

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Translation of bacteriophage Q RNA by cytoplasmic extracts of mammalian cells.

Authors:  T G Morrison; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

3.  Inhibitors of protein synthesis in eukaryotes: tools in cell research.

Authors:  A P Grollman; M T Huang
Journal:  Fed Proc       Date:  1973-06

4.  Selective and reversible inhibition of initiation of protein synthesis in mammalian cells.

Authors:  J L Saborio; S S Pong; G Koch
Journal:  J Mol Biol       Date:  1974-05-15       Impact factor: 5.469

5.  The mechanism of cycloheximide inhibition of protein synthesis in rabbit reticulocytes.

Authors:  W McKeehan; B Hardesty
Journal:  Biochem Biophys Res Commun       Date:  1969-08-15       Impact factor: 3.575

6.  Antibiotic inhibitors of the bacterial ribosome.

Authors:  B Weisblum; J Davies
Journal:  Bacteriol Rev       Date:  1968-12

7.  Peptidyltransferase inhibition by trichodermin.

Authors:  W P Tate; C T Caskey
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

8.  Antitumor alkaloids for Cephalataxus harringtonia: structure and activity.

Authors:  R G Powell; D Weisleder; C R Smith
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

9.  Inhibitors of protein biosynthesis. II. Mode of action of anisomycin.

Authors:  A P Grollman
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

10.  Mechanism of inhibition of eukaryotic protein synthesis by trichothecene fungal toxins.

Authors:  E Cundliffe; M Cannon; J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

View more
  26 in total

1.  The characterization of free, cytoskeletal and membrane-bound polysomes in Krebs II ascites and 3T3 cells.

Authors:  A Vedeler; I F Pryme; J E Hesketh
Journal:  Mol Cell Biochem       Date:  1991-02-02       Impact factor: 3.396

2.  Identification and characterization of small molecules that inhibit intracellular toxin transport.

Authors:  Jose B Saenz; Teresa A Doggett; David B Haslam
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

3.  Specificity of protein synthesis inhibitors in the inhibition of encephalomyocarditis virus replication.

Authors:  T V Ramabhadran; R E Thach
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

4.  Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I.

Authors:  Jeff D Colbert; Diego J Farfán-Arribas; Kenneth L Rock
Journal:  J Immunol       Date:  2013-10-30       Impact factor: 5.422

Review 5.  Targeting the translation machinery in cancer.

Authors:  Mamatha Bhat; Nathaniel Robichaud; Laura Hulea; Nahum Sonenberg; Jerry Pelletier; Ivan Topisirovic
Journal:  Nat Rev Drug Discov       Date:  2015-03-06       Impact factor: 84.694

6.  Pharmacokinetics of homoharringtonine in dogs.

Authors:  K Lu; N Savaraj; L G Feun; Z G Guo; T Umsawasdi; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.

Authors:  Eri Miyagi; Sandra Kao; Venkat Yedavalli; Klaus Strebel
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Central nervous system (CNS) penetration of homoharringtonine (HHT).

Authors:  N Savaraj; L G Feun; K Lu; M Leavens; R Moser; W S Fields; T L Loo
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

9.  Functional Dynamics within the Human Ribosome Regulate the Rate of Active Protein Synthesis.

Authors:  Angelica Ferguson; Leyi Wang; Roger B Altman; Daniel S Terry; Manuel F Juette; Benjamin J Burnett; Jose L Alejo; Randall A Dass; Matthew M Parks; C Theresa Vincent; Scott C Blanchard
Journal:  Mol Cell       Date:  2015-10-22       Impact factor: 17.970

10.  Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.

Authors:  L J Wilkoff; D A Dulmadge; W R Laster; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.